Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
CRISPR Therapeutics
CRSP
$5.18B
| $10.2M | ﹤0.01% |
66,564
+32,291
| +94% | +$3.82M |
|
2502
PUT
Enbridge
ENB
$111B
| $10.2M | ﹤0.01% |
318,300
+105,700
| +50% | +$3.22M |
|
2503
PUT
Chemours
CC
$2.39B
| $10.2M | ﹤0.01% |
410,200
+600
| +0.1% | +$14.3K |
|
2504
PUT
Rithm Capital
RITM
$5.79B
| $10.2M | ﹤0.01% |
1,023,000
+315,700
| +45% | +$2.79M |
|
2505
Lightspeed Commerce
LSPD
$1.38B
| $10.1M | ﹤0.01% |
144,161
-386,311
| -73% | -$17.9M |
|
|
GNRS
2506
DELISTED
Greenrose Acquisition Corp. Common Stock
GNRS
| $10.1M | ﹤0.01% |
+1,000,009
| New | +$9.88M |
|
2507
CALL
Canadian Natural Resources
CNQ
$98.9B
| $10.1M | ﹤0.01% |
859,682
+539,292
| +168% | +$5.42M |
|
2508
PUT
Travelers Companies
TRV
$77.2B
| $10.1M | ﹤0.01% |
72,100
-44,000
| -38% | -$5.65M |
|
2509
GrafTech
EAF
$199M
| $10.1M | ﹤0.01% |
94,848
+63,368
| +201% | +$5.09M |
|
2510
PUT
EPAM Systems
EPAM
$5.18B
| $10.1M | ﹤0.01% |
28,200
+3,200
| +13% | +$1.07M |
|
|
GOCO
2511
DELISTED
GoHealth
GOCO
| $10.1M | ﹤0.01% |
49,274
+47,196
| +2,271% | +$8.77M |
|
2512
Schwab Fundamental International Small Company Index ETF
FNDC
$3.18B
| $10.1M | ﹤0.01% |
+290,223
| New | +$9.38M |
|
2513
CALL
Brinker International
EAT
$10.2B
| $10.1M | ﹤0.01% |
178,300
-64,700
| -27% | -$3.2M |
|
2514
PUT
Takeda Pharmaceutical
TAK
$56.3B
| $10.1M | ﹤0.01% |
553,397
+40,497
| +8% | +$711K |
|
|
SWAV
2515
CALL
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $10.1M | ﹤0.01% |
97,100
+56,200
| +137% | +$4.87M |
|
2516
PUT
Equity Residential
EQR
$24.7B
| $10M | ﹤0.01% |
169,400
+45,300
| +37% | +$2.56M |
|
2517
PUT
Nokia
NOK
$60.1B
| $10M | ﹤0.01% |
2,567,900
-283,700
| -10% | -$1.12M |
|
2518
PUT
Workhorse Group
WKHS
$33.3M
| $10M | ﹤0.01% |
169
-3
| -2% | -$195K |
|
2519
PUT
ARK Blockchain & Fintech Innovation ETF
ARKF
$771M
| $10M | ﹤0.01% |
201,800
+191,600
| +1,878% | +$8.64M |
|
2520
CALL
Axsome Therapeutics
AXSM
$11.2B
| $10M | ﹤0.01% |
123,100
-40,900
| -25% | -$3.06M |
|
2521
CALL
CleanSpark
CLSK
$3.1B
| $10M | ﹤0.01% |
344,900
+205,800
| +148% | +$2.62M |
|
2522
CALL
Churchill Downs
CHDN
$6.33B
| $9.99M | ﹤0.01% |
102,600
-16,800
| -14% | -$1.53M |
|
|
HZNP
2523
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $9.99M | ﹤0.01% |
136,600
+9,900
| +8% | +$736K |
|
2524
CALL
Annaly Capital Management
NLY
$17.6B
| $9.99M | ﹤0.01% |
295,475
-184,825
| -38% | -$5.72M |
|
2525
PennyMac Financial
PFSI
$4.05B
| $9.97M | ﹤0.01% |
152,004
-167,890
| -52% | -$9.99M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.